SUBJECT: DESIGN COMPANY NOVARTIS HELLAS pharmaceuticals firms PEST ANALYSIS To understand the impact of the environment in any industry‚ it is imperative to consider four main factors that influence this particular political‚ economic‚ social and technological factors. It is a fact that in Greece factors are rather disproportionate influence on the functioning of a healthy market competition. The business environment is regulated by opaque procedures‚ middlemen‚ bureaucrats‚ businessmen and
Premium Pharmacology Pharmaceutical industry Pharmacy
Pharmaceutical drugs have played a large role in increasing the lifespan development‚ health and overall wellness of millions of people in the past century. These drugs along with other medical advancements have been able to cure and treat several diseases and conditions. Contradictory to the benefits‚ due to factors as simple as improper disposal‚ pharmaceutical drugs have also introduced several unintended negative effects on the environment and organisms. The extent of these impacts is not fully
Premium Medicine Health care Pharmacology
MAPPING THE COMPETENCIES OF PHARMACEUTICAL GRADUATES IN CHENNAI INDEX Certificate Declaration Acknowledgement Table of Contents List of Tables List of Figures |S.NO. |CONTENTS |PAGE NO. | |Chapter 1 |Introduction |1 | |1.1 |Background
Premium Human resource management Skill Organizational studies and human resource management
Threat of new entrants is relatively high. Companies forming alliances are potential rivals. Even if earlier such company was not considered to be a threat‚ after merging with some research and development company or forming alliance with another pharmaceutical company it would become a rival to Eli Lilly. The threat is however weakened by significant research and development costs necessary to successfully enter the business. Eli Lilly’s focus on a relatively narrow market of sedatives and antidepressants
Premium Pharmacology Generic drug Pharmaceutical industry
Situational Analysis: Cambridge Sciences Pharmaceuticals (CSP) is a global pharmaceutical company with over $25 billion in global sales. It has extensive experience bringing drugs to market including its most profitable drug‚ Zimistat. Metabical‚ is CSP’s new weight loss drug that is being brought to market by CSP and is targeted to individuals categorized as overweight (BMIs 25-30). Metabical is the culmination of 10 years and $400 million dollars in R&D and is uniquely positioned as the only
Premium Obesity Weight loss Medicine
BMI View: Data released by the Turkish drugmakers association for 2013 sales corresponds with our own forecasts. We have also modified our pharmaceutical sales forecast for 2014 and beyond to reflect the volatile exchange rate situation. We now see Turkey’s lustre as an emerging pharmaceutical market regressing over the medium term. We believe that the business environment will continue to impede the industry and see very little scope for the central government to enact business-friendly reform in
Free Pharmacology Food and Drug Administration Medicine
couple of hundred manufacturing facilities with huge potential in pharmaceutical formulations‚ Bangladesh is treading on a new path of industry economics for self-reliance. With a view to minimizing the import dependency on basic drugs‚ the country is building up its own capability in the manufacturing of active pharmaceutical ingredients(APIs)‚ base materials and other allied industry inputs. In the last two decades‚pharmaceutical industry in Bangladesh has grown at a considerable rate. This has
Free Pharmacology Pharmacy Drug
this paper is to analyze federal antitrust enforcers are investigating whether a multinational pharmaceutical company has attempted to minimize the impact of generic competition to one of its most profitable prescription drugs. This anti-depressant drug is the company’s best seller‚ with sales last year of $2.11 billion‚ representing a 22% increase from the year before. I will review whether pharmaceutical companies have engaged in activities that will prevent generic brands to the prescription drug
Premium Pharmacology Generic drug Food and Drug Administration
INTRODUCTION 1.1 OVERVIEW: Trade Related Aspects of Intellectual property Rights was put into effect in the developed countries since Jan 1996. And it will be implemented in Less Developed Countries starting from Jan 2006. Egypt is preparing its pharmaceutical industry for such agreement. A sense of optimism is expressed in the rich North. While a sense of pessimism is expressed in the poor South. Research and Development companies feel quite secure. Reverse Engineering companies (producing imitated
Premium Patent
PHARMACEUTICAL PATENTING IN INDIA:PROBLEM OF PUBLIC ACCESS TO HEALTH TABLE OF CASES 1) Novartis AG v. Union of India‚ (2007) 4 MLJ 1153 2) Bayer Corporation & Others v. Cipla‚ UOI & others‚ 2009(41) PTC 643 (Del). INTRODUCTION A pharmaceutical drug‚ also referred to as medicine‚ is a chemical substance used in the medication or in the preparation of medication for treatment‚ cure‚ prevention or diagnosis of disease. The definition of the term drug includes articles intended for use in
Premium Patent